MS
REGN icon

Maven Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Maven Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400
Closed -$329K – 1157
2023
Q3 		$329K Sell
400
-3,300
-89% -$2.59M ﹤0.01% 923
2023
Q2 		$2.66M Buy
3,700
+3,300
+825% +$2.54M 0.04% 227
2023
Q1 		$329K Sell
400
-100
-20% -$75.4K 0.01% 765
2022
Q4 		$361K Sell
500
-2,600
-84% -$1.92M 0.01% 645
2022
Q3 		$2.14M Buy
3,100
+400
+15% +$252K 0.04% 302
2022
Q2 		$1.6M Buy
2,700
+200
+8% +$130K 0.05% 258
2022
Q1 		$1.75M Sell
2,500
-200
-7% -$127K 0.06% 220
2021
Q4 		$1.71M Buy
2,700
+1,600
+145% +$984K 0.05% 229
2021
Q3 		$666K Sell
1,100
-2,200
-67% -$1.37M 0.02% 568
2021
Q2 		$1.84M Buy
3,300
+2,100
+175% +$1.06M 0.07% 257
2021
Q1 		$568K Buy
+1,200
New +$584K 0.03% 593
2020
Q4 		– Sell
-1,500
Closed -$851K – 812
2020
Q3 		$851K Hold
1,500
– – 0.07% 274
2020
Q2 		$935K Buy
+1,500
New +$851K 0.06% 217

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Maven Securities's REGN Position: Q1 2024 in Review

Maven Securities sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 702 shares — an estimated $617K sold.

Maven Securities first reported a position in REGN in Q2 2020 and held it in 9 quarters. The position peaked at $772K in Q4 2020. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Maven Securities reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Maven Securities sold 702 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $617K.
  • Maven Securities first reported a position in Regeneron Pharmaceuticals in Q2 2020 and held it in 9 quarters.
  • Maven Securities's Regeneron Pharmaceuticals position peaked at $772K in Q4 2020.
  • 1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Maven Securities's 13F filing for Q1 2024, filed 14 May 2024.